Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 09, 2024

SELL
$145.6 - $158.88 $60,715 - $66,252
-417 Reduced 7.83%
4,911 $769,000
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $673,930 - $754,974
-4,327 Reduced 44.82%
5,328 $829,000
Q2 2023

Jul 25, 2023

SELL
$154.35 - $166.11 $418,597 - $450,490
-2,712 Reduced 21.93%
9,655 $1.6 Million
Q1 2023

Apr 14, 2023

BUY
$151.05 - $180.26 $179,598 - $214,329
1,189 Added 10.64%
12,367 $1.92 Million
Q4 2022

Jan 10, 2023

BUY
$160.2 - $179.79 $348,915 - $391,582
2,178 Added 24.2%
11,178 $0
Q3 2022

Oct 20, 2022

BUY
$161.33 - $179.52 $40,977 - $45,598
254 Added 2.9%
9,000 $1.48 Million
Q2 2022

Jul 08, 2022

BUY
$168.19 - $186.01 $39,020 - $43,154
232 Added 2.72%
8,746 $1.56 Million
Q1 2022

Apr 12, 2022

SELL
$158.14 - $179.59 $20,716 - $23,526
-131 Reduced 1.52%
8,514 $1.53 Million
Q4 2021

Jan 12, 2022

BUY
$155.93 - $173.01 $274,124 - $304,151
1,758 Added 25.53%
8,645 $1.48 Million
Q3 2021

Oct 12, 2021

BUY
$161.5 - $179.47 $27,132 - $30,150
168 Added 2.5%
6,887 $1.11 Million
Q2 2021

Jul 09, 2021

SELL
$159.48 - $171.07 $143,372 - $153,791
-899 Reduced 11.8%
6,719 $1.14 Million
Q1 2021

Apr 14, 2021

BUY
$153.07 - $170.48 $171,438 - $190,937
1,120 Added 17.24%
7,618 $1.22 Million
Q4 2020

Jan 13, 2021

BUY
$137.11 - $157.38 $890,940 - $1.02 Million
6,498 New
6,498 $1.04 Million
Q4 2020

Jan 12, 2021

SELL
$137.11 - $157.38 $1.06 Million - $1.22 Million
-7,748 Closed
0 $0
Q3 2020

Oct 13, 2020

BUY
$140.38 - $153.83 $1.09 Million - $1.19 Million
7,748 New
7,748 $1.18 Million
Q4 2017

Feb 09, 2018

SELL
$131.22 - $143.62 $122,953 - $134,571
-937 Closed
0 $0
Q3 2017

Nov 01, 2017

BUY
$129.47 - $135.38 $258 - $270
2 Added 0.21%
937 $122,000
Q2 2017

Aug 16, 2017

BUY
N/A
935
935 $124,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Mcia Inc Portfolio

Follow Mcia Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcia Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcia Inc with notifications on news.